Back
Amicus Therapeutics Vs. Krystal Biotech Industry Stock Comparison
Sell
44
FOLD
Amicus Therapeutics
Last Price:
10.10
Seasonality Move:
8.32%
Buy
52
KRYS
Krystal Biotech
Last Price:
177.41
Seasonality Move:
21.68%
Sell
44
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy, Sell or Hold?
- The current Amicus Therapeutics [FOLD] share price is $10.38. The Score for FOLD is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- FOLD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Krystal Biotech (KRYS)
is a Buy
Is Krystal Biotech a Buy, Sell or Hold?
- The current Krystal Biotech [KRYS] share price is $184.22. The Score for KRYS is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- KRYS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FOLD Stock Price Chart
What is Amicus Therapeutics's stock price today?
-
The Amicus Therapeutics share price today is $10.38
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing selling pressure, which indicates risk of future bearish movement.
KRYS Stock Price Chart
What is Krystal Biotech's stock price today?
-
The Krystal Biotech share price today is $184.22
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KRYS is experiencing selling pressure, which indicates risk of future bearish movement.
FOLD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 36.89 | Sell |
| Chaikin Money Flow: | -1470064 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.52 - 11.72) | Sell |
| Bollinger Bands (100): | (10.2 - 11.54) | Sell |
KRYS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.35 | Buy |
| Relative Strength Index (14 RSI): | 52.64 | Buy |
| Chaikin Money Flow: | -175251 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (172.09 - 185.85) | Buy |
| Bollinger Bands (100): | (176.65 - 199.01) | Sell |
FOLD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.98 | Sell |
| 20-day SMA: | 11.32 | Sell |
| 50-day SMA: | 11.06 | Sell |
| 200-day SMA: | 11.08 | Sell |
| 8-day EMA: | 10.86 | Sell |
| 20-day EMA: | 11.06 | Sell |
| 50-day EMA: | 11.04 | Sell |
| 200-day EMA: | 11.1 | Sell |
KRYS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 185.05 | Sell |
| 20-day SMA: | 179.61 | Buy |
| 50-day SMA: | 181.46 | Buy |
| 200-day SMA: | 172.74 | Buy |
| 8-day EMA: | 185.77 | Sell |
| 20-day EMA: | 182.03 | Buy |
| 50-day EMA: | 182.16 | Buy |
| 200-day EMA: | 170.09 | Buy |
Amicus Therapeutics Earnings Growth & FOLD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $0.21 per share.
Krystal Biotech Earnings Growth & KRYS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.65 per share, and an increase next year of $1.53 per share.
Amicus Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Krystal Biotech Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||